RT @EMSwami: HCQ still doesn't work for prophylaxis https://t.co/U4qiZDCAuv Infection rate in both HCQ + placebo group ~ 6.5% Excellent w…
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/xuvLRywUqS via @JAMAInternalMed part of @JAMANetwork
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/cOiMn9ZHbs via @JAMAInternalMed part of @JAMANetwork This randomized clinical trial did not detect a reduction in SARS- CoV-2 tr
NOT DOUBTS¡ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/lrYNkZzAIb a través de @JAMAInternalMed part of @JAMANetwork
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
The RCT study showed that prophylactic HCQ does not have a benefit for preventing #COVID19 via @JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/WGYKfECtWD
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
Among hospital-based health care workers daily HCQ did not prevent SARS-CoV-2 infection Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/AbX6pOjLiM via @JAMAInternalMed part of
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Among hospital-based health care workers, daily hydroxychloroquine prophylaxis did not prevent SARS-CoV-2 infection as compared to placebo https://t.co/J3DSUwYxj0 via @JAMAInternalMed part of @JAMANetwork
Another revelation about HCQ ! Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/1I6QV4AaM1 via @JAMAInternalMed part of @JAMANetwork
Hydroxychloroquine 600mg/jour X 8 semaines ne prévient pas plus l'infection au #SARSCoV2 que le placebo chez les soignants exposés au virus. Dommage, mais c'est la fin de l'histoire. #COVID19 https://t.co/6J8vfbtlcD via @JAMAInternalMed part of @JAMANetwo
@_MiguelHernan @NoahHaber another RCT was just published today that concluded, "there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19." https:
Efficacy and Safety of #Hydroxychloroquine vs Placebo for Pre-exposure #SARSCoV2 #Prophylaxis Among Healthcare Workers https://t.co/AeuMbCJbNO via @JAMAInternalMed part of @JAMANetwork
Para confirmar lo contrario de metanalisis tenemos un trial bien hecho
RT @daniel_kraft: Hydroxychloroquine no more effective than placebo in preventing #COVID19 https://t.co/OZeIGM4g8w Randomized study of fro…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @daniel_kraft: Hydroxychloroquine no more effective than placebo in preventing #COVID19 https://t.co/OZeIGM4g8w Randomized study of fro…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
Hydroxychloroquine no more effective than placebo in preventing #COVID19 https://t.co/OZeIGM4g8w Randomized study of frontline healthcare workers in @JAMA_current https://t.co/XjMiWYG3Fo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @iic_a: Satu lagi hasil uji klinis (RCT). Pemakaian secara prophylactic Hydroxychloroquine TIDAK mencegah infeksi dengan SARS-CoV2. htt…
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
RT @pash22: HCQ prophylaxis for Covid-19 takes another rock-bottom plunge https://t.co/bih78b398B via @BenjaminAbella et al @abledoc @ProfS…
RT @EViteriOft: La #hidroxicloroquina no actúa como preventivo de #COVID19
RT @voyager_2000: 1/ Due to the long halflife of #Hydroxychloroquine 600 mg daily for 56 days represents a monster dose! 5 days x 400 mg l…
No surprises here: Among hospital-based health care workers, daily hydroxychloroquine did not prevent SARS-CoV-2 infection. Please be safe and #WearAMask ! https://t.co/oqhdn7DTKt
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @EMSwami: HCQ still doesn't work for prophylaxis https://t.co/U4qiZDCAuv Infection rate in both HCQ + placebo group ~ 6.5% Excellent w…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり少なくなりました。 https://t.co/tnhypv9y6U
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
Thread
RT @gary_lyman: Well done study. The senior author Ravi K Amaravadi presented the results of PATCH simultaneously today on a Penn Med confe…
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
Government still flogging HCQS? Despite knowing that it doesn’t protect against COVID and causes irreversible damage ?
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/R34YIQKHlc vía @JAMAInternalMed part of @JAMANetwork
Where's the zinc? Dr. Zelenko statement Hydroxychloroquine is the gun! Zinc is the bullet! It is the propelled zinc used as preventative that stops COVID viral entry. It is the propelled zinc with early COVID infection that reduces viral workload. Anot
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @gary_lyman: Well done study. The senior author Ravi K Amaravadi presented the results of PATCH simultaneously today on a Penn Med confe…
Well done study. The senior author Ravi K Amaravadi presented the results of PATCH simultaneously today on a Penn Med conference CANCER AND COVID-19 following keynote by @DrAnthonyF Earlier CCC19 results highlighted @NicoleKuderer Faucihttps://www.med
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
@cbai77 The link to the study was in the article. I’ll provide a link. No, I don’t always believe CNN. I sometimes believe CNN. I think RCTs are good evidence. Along with all the evidence we had before. I was a hydrocychloroquine hopeful. I wish I was
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Por enésima vez: la hidroxicloroquina no sirve para nada contra la covid-19.
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @EViteriOft: La #hidroxicloroquina no actúa como preventivo de #COVID19 https://t.co/K5sEhmVACW
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
La #hidroxicloroquina no actúa como preventivo de #COVID19
RT @EMSwami: HCQ still doesn't work for prophylaxis https://t.co/U4qiZDCAuv Infection rate in both HCQ + placebo group ~ 6.5% Excellent w…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
@statsepi Meanwhile in jama an rct of healthworkers showed no significant benefits of HCQ over placebo, and had to be stopped early due to prolonged QTc https://t.co/rlLLpG5qxE
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Daily hydroxychloroquine administration to healthcare workers as pre-exposure prophylaxis against SARS-CoV-2 infection did not change infection risk, although double-blind placebo-controlled RT was ended early and may be underpowered via @JAMAInternalMed
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @mellziland: Mais dados para se somar a MUITOS dados mostrando que a hidroxicloroquina não funciona https://t.co/TXDRde9N6L
RT @mellziland: Mais dados para se somar a MUITOS dados mostrando que a hidroxicloroquina não funciona
Efficacy,Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARSCoV2 Prophylaxis in HCW:https://t.co/TuQ7m3jUlA clinical benefit of HCQ administered daily for 8 wks(pre-exposure prophylaxis)in hosp-based HCWs exposed to patients with COVID19. https:/
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @rigotordoc: Eficacia y seguridad de la #hidroxicloroquina frente al placebo para la #profilaxis del #SARSCoV2 antes de la exposición en…
RT @rigotordoc: Eficacia y seguridad de la #hidroxicloroquina frente al placebo para la #profilaxis del #SARSCoV2 antes de la exposición en…
RT @rigotordoc: Eficacia y seguridad de la #hidroxicloroquina frente al placebo para la #profilaxis del #SARSCoV2 antes de la exposición en…
RT @ndanmontero: No hay ningún beneficio respecto a la hidroxicloroquina en calidad de profilaxis para trabajadores de salud. JAMA Intern…
RT @isabellesmullen: It was a real privilege to work on this rigorous, timely trial with the PATCH team and the healthcare workers who part…
1/ Due to the long halflife of #Hydroxychloroquine 600 mg daily for 56 days represents a monster dose! 5 days x 400 mg loading plus 400 mg weekly should have the same protective effect against #Covid19 #Coronavirus #SARSCoV2. Most important, no #zinc giv
RT @ElianaJolkovsky: The only study to assess the prophylactic efficacy of hydroxychloroquine against SARS-CoV-2 transmission (using labora…
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @iic_a: Satu lagi hasil uji klinis (RCT). Pemakaian secara prophylactic Hydroxychloroquine TIDAK mencegah infeksi dengan SARS-CoV2. htt…